FdaApplication
BLA 761034
Identifiers
- fda_app_no: BLA761034
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2016-05-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TECENTRIQ | ATEZOLIZUMAB | 1,200MG/20ML (60MG/ML) | Injection |
| TECENTRIQ | — | 840MG/14ML (60MG/ML) | Injection |
2 products